CRB2 Gene Focal Segmental Glomerulosclerosis Type 9 NGS Genetic DNA Test - $500 USA | Comprehensive Kidney Disorder Genetic Testing
Sale!

CRB2 Gene Focal Segmental Glomerulosclerosis Type 9 NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The CRB2 Gene Focal Segmental Glomerulosclerosis Type 9 NGS Genetic DNA Test is a cutting-edge genetic analysis that identifies mutations in the CRB2 gene associated with hereditary kidney disorders. This comprehensive test utilizes Next-Generation Sequencing technology to detect specific genetic variants responsible for focal segmental glomerulosclerosis type 9, a serious kidney condition affecting glomerular filtration. The test provides crucial information for early diagnosis, personalized treatment planning, and family risk assessment. Available for $500 USD, this advanced genetic screening helps identify individuals at risk for progressive kidney disease and enables proactive medical management. Results are typically available within 3-4 weeks from sample collection.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

CRB2 Gene Focal Segmental Glomerulosclerosis Type 9 NGS Genetic DNA Test

Comprehensive Genetic Analysis for Hereditary Kidney Disorders

The CRB2 Gene Focal Segmental Glomerulosclerosis Type 9 NGS Genetic DNA Test represents a breakthrough in precision medicine for kidney health. This advanced diagnostic tool utilizes cutting-edge Next-Generation Sequencing technology to identify specific mutations in the CRB2 gene that are directly linked to focal segmental glomerulosclerosis type 9, a hereditary form of kidney disease affecting glomerular function.

What This Test Measures and Detects

This comprehensive genetic analysis specifically targets the CRB2 gene, which plays a crucial role in maintaining the structural integrity of kidney glomeruli. The test identifies:

  • Pathogenic variants in the CRB2 gene associated with FSGS type 9
  • Single nucleotide polymorphisms (SNPs) affecting kidney function
  • Inheritance patterns of genetic mutations
  • Risk assessment for developing progressive kidney disease
  • Genetic markers for early intervention opportunities

Who Should Consider This Genetic Test

This test is particularly recommended for individuals experiencing:

  • Unexplained proteinuria or elevated protein levels in urine
  • Progressive kidney function decline without clear cause
  • Family history of kidney disease or FSGS
  • Early-onset nephrotic syndrome symptoms
  • Resistance to standard steroid treatments for kidney conditions
  • Planning for kidney transplantation evaluation
  • Family planning considerations with known kidney disease history

Key Benefits of Genetic Testing

  • Early Detection: Identify genetic predisposition before significant kidney damage occurs
  • Personalized Treatment: Tailor medical interventions based on specific genetic findings
  • Family Risk Assessment: Provide valuable information for relatives’ health planning
  • Proactive Management: Implement preventive measures to preserve kidney function
  • Reproductive Planning: Make informed decisions about family planning
  • Reduced Diagnostic Uncertainty: Provide definitive answers for complex kidney conditions

Understanding Your Test Results

Your genetic test results will provide clear insights into your CRB2 gene status:

  • Positive Result: Indicates the presence of pathogenic CRB2 gene mutations associated with FSGS type 9, requiring specialized nephrology care and monitoring
  • Negative Result: Suggests no detected mutations in the CRB2 gene, though continued monitoring may be recommended based on clinical symptoms
  • Variant of Uncertain Significance: Identifies genetic changes with unknown clinical impact, requiring ongoing research and periodic re-evaluation
  • Carrier Status: Determines if you carry one copy of a mutated gene, important for family planning considerations

Test Pricing and Details

Test Component Details
Test Name CRB2 Gene Focal Segmental Glomerulosclerosis Type 9 NGS Genetic DNA Test
Discount Price $500 USD
Regular Price $700 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Method Next-Generation Sequencing (NGS) Technology

Pre-Test Requirements

Before undergoing testing, patients should provide:

  • Complete clinical history relevant to kidney function and symptoms
  • Participation in a genetic counseling session to understand implications
  • Development of a detailed pedigree chart documenting family health history
  • Discussion of potential outcomes and their impact on medical management

Nationwide Testing Availability

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network of certified genetic counselors and nephrology specialists ensures comprehensive care coordination.

Take Control of Your Kidney Health Today

Don’t wait for symptoms to progress. Early genetic detection of CRB2 gene mutations can significantly impact your long-term kidney health and quality of life. Our team of genetic specialists and nephrologists are ready to guide you through the testing process and help interpret your results for optimal health management.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic counseling session and book your CRB2 Gene Focal Segmental Glomerulosclerosis Type 9 NGS Genetic DNA Test. Take the first step toward personalized kidney health management and gain valuable insights into your genetic predisposition.

SKU: 71463aaacf04 Category: